Horiana has joined the Athagoras Group, expanding athagoras’ pan‑European real‑world evidence capabilities with deep French health‑data expertise.

Athagoras Group is a Life Sciences platform uniting specialized consulting firms to accelerate the development and delivery of next-generation therapies. Athagoras Group operates across Europe and the  U.S., employing over 500 professionals in 14 countries, and focuses on areas such as Real-World Evidence (RWE), Market Access, Regulatory Affairs (RA), Pharmacovigilance (PV), Data, AI, and Technology to help innovators bring therapies to patients efficiently and compliantly. 

HORIANA is a premier consulting company dedicated to biostatistics and data science, designing and conducting Healthcare & Lifescience Studies.

– Expertise and Consulting: Specialized guidance in biostatistics/data science, clinical development generation plan, epidemiology, and pharmacoepidemiology.

– Synthetic Control Groups: Implementation of Synthetic Control Groups and External Control Arms to derisk clinical studies and optimize phase II studies.

– Evidence Synthesis: Conducting External Comparators (Network Meta-Analysis and Matching-Adjusted Indirect Comparison) to develop bespoke protocol and clinical plan.

– Secondary Databases Studies: Development and analysis of studies using claims data (e.g., SNDS) or cohorts/registries.